New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
08:12 EDTHRTXHeron Therapeutics reports Q4 EPS (75c), consensus (53c)
The company said "Net loss was higher in the FY13 quarter primarily due to increased spending related to manufacturing development expenses and higher personnel costs, including stock compensation expense."
News For HRTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 15, 2015
07:28 EDTHRTXHeron Therapeutics shares remain undervalued, says Brean Capital
Subscribe for More Information
May 14, 2015
08:01 EDTHRTXHeron Therapeutics says FDA accepts propsal to use 505(b)(2) pathway for HTX-019
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use